Tech Company Financing Transactions

SolasCure Funding Round

Seneca Partners, BRAIN Biotech and EVA Pharma participated in a $13.4 million Series B funding round for SolasCure. The round was announced on 3/27/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Wellington House East Rd
Cambridge, England, CB1 1BH
UK

Phone

+44 (0)1223 60 3535

Website

www.solascure.com

Email Address

[email protected]

Overview

The company was born in 2017 as a spin-off from BRAIN Biotech AG, a leading German biotech company that focuses on harnessing biological diversity to develop innovative solutions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sam Bakri

        

Chief Financial Officer

Oliver Schofield

        

Chief Medical Officer

David Goldsmith

        

Chief Technical Officer

Bela Kelety

        

Browse more venture capital transactions:

Prev: 3/27/2023: Kim Technologies venture capital transaction
Next: 3/27/2023: Paraform venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary